RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 112.00
+10.00 (9.80%)
Sep 29, 2025, 4:08 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 65.08 billion as of September 29, 2025. Its market cap has increased by 447.66% in one year.
Market Cap
65.08B
Enterprise Value
66.61B
Revenue
2.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
112.00
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 65.08B, an increase of 94.92%. That is a compound annual growth rate of 14.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 61.14B | 336.56% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | 46.53B | 39.37% |
| Nov 9, 2020 | 33.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 279.26B |
| Hansoh Pharmaceutical Group Company | 210.92B |
| JD Health International | 206.50B |
| Innovent Biologics | 159.71B |
| WuXi Biologics | 158.73B |
| Sino Biopharmaceutical | 142.12B |
| Akeso | 122.24B |
| Sichuan Kelun-Biotech Biopharmaceutical | 113.38B |